Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1899 1
1941 1
1953 1
1972 1
1974 1
1975 1
1976 2
1977 4
1978 3
1979 2
1980 4
1981 1
1982 1
1985 3
1986 5
1987 3
1988 2
1989 2
1990 4
1991 4
1992 4
1993 4
1994 4
1995 3
1996 6
1997 2
1999 1
2000 2
2001 3
2002 2
2003 3
2004 3
2005 7
2006 1
2007 7
2008 2
2009 3
2011 5
2012 2
2013 4
2014 5
2015 5
2016 1
2017 2
2018 4
2019 1
2020 2
2021 4
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Targeting UGCG Overcomes Resistance to Lysosomal Autophagy Inhibition.
Jain V, Harper SL, Versace AM, Fingerman D, Brown GS, Bhardwaj M, Crissey MAS, Goldman AR, Ruthel G, Liu Q, Zivkovic A, Stark H, Herlyn M, Gimotty PA, Speicher DW, Amaravadi RK. Jain V, et al. Among authors: brown gs. Cancer Discov. 2023 Feb 6;13(2):454-473. doi: 10.1158/2159-8290.CD-22-0535. Cancer Discov. 2023. PMID: 36331284 Free PMC article.
Inferring Negative Molecular Biomarker Data at Scale.
McBratney AE, Holmes BA, Brown GS, Warrier R, Berry AB. McBratney AE, et al. Among authors: brown gs. JCO Clin Cancer Inform. 2023 Mar;7:e2200158. doi: 10.1200/CCI.22.00158. JCO Clin Cancer Inform. 2023. PMID: 36888934 Free article.
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma.
Jagirdar K, Portuallo ME, Wei M, Wilhide M, Bravo Narula JA, Robertson BM, Alicea GM, Aguh C, Xiao M, Godok T, Fingerman D, Brown GS, Herlyn M, Elad VM, Guo X, Toska E, Zabransky DJ, Wubbenhorst B, Nathanson KL, Kwatra S, Goyal Y, Ji H, Liu Q, Rebecca VW. Jagirdar K, et al. Among authors: brown gs. Oncogene. 2024 Feb;43(6):395-405. doi: 10.1038/s41388-023-02900-6. Epub 2023 Dec 8. Oncogene. 2024. PMID: 38066089 Free PMC article.
Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas.
Rebecca VW, Xiao M, Kossenkov A, Godok T, Brown GS, Fingerman D, Alicea GM, Wei M, Ji H, Bravo J, Chen Y, Fane ME, Villanueva J, Nathanson K, Liu Q, Gopal YNV, Davies MA, Herlyn M. Rebecca VW, et al. Among authors: brown gs. bioRxiv [Preprint]. 2023 Jan 21:2023.01.20.524923. doi: 10.1101/2023.01.20.524923. bioRxiv. 2023. PMID: 36711814 Free PMC article. Preprint.
Promoting health equity with HBCUs: Breaking away from structural racism.
Waite R, Varghese J, VanRiel Y, Smith T, Singletary G, Shtayermman O, Ragsdale BL, McCune NM, Holton C, Ferguson PE, Brown GS, Brewington J, Boston-Leary K, Beard K. Waite R, et al. Among authors: brown gs. Nurs Outlook. 2023 Mar-Apr;71(2):101913. doi: 10.1016/j.outlook.2022.101913. Epub 2023 Jan 21. Nurs Outlook. 2023. PMID: 36690528
138 results